80岁及以上患者首次自体动静脉内瘘长期通畅性的竞争风险分析
单中心回顾性队列纳入416例2017-2020年首次自体动静脉内瘘患者,随访至2025年3月。≥80岁占26.2%,其动脉粥样硬化和静脉直径<2.5mm更多,但两组主要通畅率损失累积发生率无差异(Gray P=.710),年龄≥80岁非独立危险因素。
要点
- 年龄≥80岁不应单独作为自体动静脉内瘘的禁忌。
- 近端吻合与主要通畅率损失风险降低独立相关。
- 静脉直径<2.5mm与主要通畅率损失风险升高独立相关。
核心结论
- 在适合自体动静脉内瘘的患者中,年龄≥80岁与主要通畅率损失无独立关联,但连续年龄敏感性分析提示每10年风险轻度增加。
研究设计与样本
- 单中心回顾性队列,纳入416例2017-2020年首次自体动静脉内瘘患者,随访至2025年3月,死亡作为竞争事件。
主要发现
- ≥80岁患者109例(26.2%),中位随访48个月。
- ≥80岁组动脉粥样硬化(67.0% vs 47.9%,P<.001)、静脉直径<2.5mm(22.0% vs 13.4%,P=.030)更多,踝臂指数(1.09 vs 1.16,P<.001)和趾臂指数(0.69 vs 0.76,P=.002)更低。
- 主要通畅率损失累积发生率两组无差异(Gray P=.710),36个月估计值分别为43.2%和38.0%。
- 年龄≥80岁与主要通畅率损失无独立关联(sHR 1.12,95%CI 0.74-1.70),但连续年龄每增加10年风险升高(sHR 1.20,95%CI 1.04-1.39)。
- 近端吻合风险更低(sHR 0.57,95%CI 0.37-0.88),静脉直径<2.5mm风险更高(sHR 1.70,95%CI 1.05-2.75)。
关键数值与推荐
- 主要通畅率损失36个月累积发生率:≥80岁组43.2%,<80岁组38.0%(Gray P=.710)。
- 年龄≥80岁 vs <80岁主要通畅率损失sHR 1.12(95%CI 0.74-1.70)。
- 连续年龄每增加10年主要通畅率损失sHR 1.20(95%CI 1.04-1.39)。
- 近端吻合sHR 0.57(95%CI 0.37-0.88),静脉直径<2.5mm sHR 1.70(95%CI 1.05-2.75)。
- 两组60个月内永久废弃瘘管均<10%,≥80岁组60个月生存率82.0%。
临床怎么用
- 对≥80岁但血管条件合适的患者,不应仅因年龄拒绝自体动静脉内瘘。
- 术前应评估静脉直径和动脉粥样硬化情况,静脉<2.5mm者需谨慎。
- 近端吻合可能降低主要通畅率损失风险,可作为术式选择参考。
局限性
- 单中心回顾性设计。
- 存在随访丢失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Whether chronological age predicts arteriovenous fistula (AVF) durability remains uncertain. We compared primary patency between patients aged ≥80 and <80 years using competing-risk analysis and examined relevant vascular characteristics. METHODS: This single-center retrospective cohort included 416 consecutive patients undergoing first autogenous AVF creation during 2017-2020, with follow-up through March 2025. Intraoperative vessel diameters, macroscopic arterial atherosclerosis and preoperative ankle-brachial and toe-brachial indices were prospectively recorded. Death before primary patency loss was treated as a competing event. Cumulative incidence was estimated using Aalen-Johansen and compared using Gray's test. Associations were assessed using Fine-Gray and cause-specific Cox regression, with age modeled continuously in a sensitivity analysis. RESULTS: Among 416 patients, 109 (26.2%) were aged ≥80 years. Median follow-up was 48 months. Older patients had more macroscopic arterial atherosclerosis (67.0% vs 47.9%; P<.001), lower ankle-brachial (1.09 vs 1.16; P<.001) and toe-brachial indices (0.69 vs 0.76; P=.002), and more venous diameters <2.5 mm (22.0% vs 13.4%; P=.030). The cumulative incidence of primary patency loss did not differ between groups (Gray P = .710), with 36-month estimates of 43.2% and 38.0%. Age ≥80 years was not independently associated with primary patency loss (subdistribution hazard ratio [sHR], 1.12; 95% CI, 0.74-1.70), whereas each 10-year increase was associated with higher risk in a sensitivity analysis (sHR, 1.20; 95% CI, 1.04-1.39). Proximal anastomosis was associated with lower risk (sHR, 0.57; 95% CI, 0.37-0.88), and venous diameter <2.5 mm with higher risk (sHR, 1.70; 95% CI, 1.05-2.75). Assisted primary and secondary patency did not differ. Fewer than 10% of fistulas were permanently abandoned by 60 months in either group, and 60-month survival among older patients was 82.0%. CONCLUSIONS: Among patients selected for autogenous AVF creation, age ≥80 years was not independently associated with primary patency loss, whereas a continuous-age sensitivity analysis suggested a modest increase in risk per decade. These findings suggest that an age threshold alone should not determine AVF candidacy in otherwise suitable patients, although interpretation is tempered by loss to follow-up.
引用
- Doita T, Nakamura T, Yamakura T, et al. Long-term patency outcomes after first autogenous arteriovenous fistula creation in patients aged 80 years or older: a competing-risk analysis. J Vasc Surg. 2026. PMID: 42946072. doi:10.1016/j.jvs.2026.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。